Publications by authors named "Jiuling Yang"

Claim this Profile
I
Inflammation switches the chemoattractant requirements for naive lymphocyte entry into lymph nodes.
Kevin Y Chen, Marco De Giovanni, Ying Xu, Jinping An, Nikhita Kirthivasan, Jiuling Yang

Cell· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of MD-265: A Potent MDM2 Degrader That Achieves Complete Tumor Regression and Improves Long-Term Survival of Mice with Leukemia.
Angelo Aguilar, Jiuling Yang, Yangbing Li, Donna McEachern, Liyue Huang

J Med Chem· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PVRL2 Suppresses Antitumor Immunity through PVRIG- and TIGIT-independent Pathways.
Jiuling Yang, Li Wang, James R Byrnes, Lisa L Kirkemo, Hannah Driks

Cancer Immunol Res· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cell-surface tethered promiscuous biotinylators enable comparative small-scale surface proteomic analysis of human extracellular vesicles and cells.
Lisa L Kirkemo, Susanna K Elledge, Jiuling Yang, James R Byrnes, Jeff E Glasgow

Elife· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Simple Structural Modifications Converting a Bona fide MDM2 PROTAC Degrader into a Molecular Glue Molecule: A Cautionary Tale in the Design of PROTAC Degraders.
Jiuling Yang, Yangbing Li, Angelo Aguilar, Zhaomin Liu, Chao-Yie Yang

J Med Chem· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of MD-224 as a First-in-Class, Highly Potent, and Efficacious Proteolysis Targeting Chimera Murine Double Minute 2 Degrader Capable of Achieving Complete and Durable Tumor Regression.
Yangbing Li, Jiuling Yang, Angelo Aguilar, Donna McEachern, Sally Przybranowski, Chao-Yie Yang

J Med Chem· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cofilin hyperactivation in HIV infection and targeting the cofilin pathway using an anti-αβ integrin antibody.
Sijia He, Yajing Fu, Jia Guo, Mark Spear, Jiuling Yang

Sci Adv· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of QCA570 as an Exceptionally Potent and Efficacious Proteolysis Targeting Chimera (PROTAC) Degrader of the Bromodomain and Extra-Terminal (BET) Proteins Capable of Inducing Complete and Durable Tumor Regression.
Chong Qin, Yang Hu, Bing Zhou, Ester Fernandez-Salas, Chao-Yie Yang, Jiuling Yang

J Med Chem· August 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of a Highly Potent, Cell-Permeable Macrocyclic Peptidomimetic (MM-589) Targeting the WD Repeat Domain 5 Protein (WDR5)-Mixed Lineage Leukemia (MLL) Protein-Protein Interaction.
Hacer Karatas, Yangbing Li, Liu Liu, Jiao Ji, Shirley Lee, Jiuling Yang

J Med Chem· June 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
LAPTM4B allele *2 is a marker of poor prognosis for gallbladder carcinoma.
Guojun Zhai, Kaowen Yan, Xiaoxu Ji, Wenrui Xu, Jiuling Yang, Hua Yang

PLoS One· March 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cardiac marker changes in subjects working at plateau level.
Zhenlu Zhang, Xianhui Kong, Shuzheng Cao, Yahui Song, Jiuling Yang

Clin Chim Acta· March 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis